Cocrystal Pharma, Inc.
COCP
$1.34
$0.02541.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.67% | -3.78% | 8.32% | 57.93% | 53.69% |
| Total Depreciation and Amortization | -33.33% | 200.00% | 16.08% | 7.77% | 2.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.32% | -13.28% | -19.61% | -96.61% | -96.05% |
| Change in Net Operating Assets | -94.02% | 36.95% | 171.88% | 80.64% | 186.36% |
| Cash from Operations | -12.40% | -2.58% | 36.74% | 22.18% | 31.58% |
| Capital Expenditure | 93.22% | 5.63% | 49.62% | 31.93% | -59.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.22% | 5.63% | 49.62% | 31.93% | -59.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | 74.07% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -100.00% | 14,385.71% | 14,888.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.84% | -35.17% | 23.31% | 41.59% | 49.89% |